Literature DB >> 9738087

Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.

C A Herzog1, J Z Ma, A J Collins.   

Abstract

BACKGROUND: Cardiovascular disease is common in patients on long-term dialysis, and it accounts for 44 percent of overall mortality in this group. We undertook a study to assess long-term survival after acute myocardial infarction among patients in the United States who were receiving long-term dialysis.
METHODS: Patients on dialysis who were hospitalized during the period from 1977 to 1995 for a first myocardial infarction after the initiation of renal-replacement therapy were retrospectively identified from the U.S. Renal Data System data base. Overall mortality and mortality from cardiac causes (including all in-hospital deaths) were estimated by the life-table method. The effect of independent predictors on survival was examined in a Cox regression model with adjustment for existing illnesses.
RESULTS: The overall mortality (+/-SE) after acute myocardial infarction among 34,189 patients on long-term dialysis was 59.3+/-0.3 percent at one year, 73.0+/-0.3 percent at two years, and 89.9+/-0.2 percent at five years. The mortality from cardiac causes was 40.8+/-0.3 percent at one year, 51.8+/-0.3 percent at two years, and 70.2+/-0.4 percent at five years. Patients who were older or had diabetes had higher mortality than patients without these characteristics. Adverse outcomes occurred even in patients who had acute myocardial infarction in 1990 through 1995. Also, the mortality rate after myocardial infarction was considerably higher for patients on long-term dialysis than for renal-transplant recipients.
CONCLUSIONS: Patients on dialysis who have acute myocardial infarction have high mortality from cardiac causes and poor long-term survival.

Entities:  

Mesh:

Year:  1998        PMID: 9738087     DOI: 10.1056/NEJM199809173391203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  155 in total

Review 1.  Cardiovascular complications of renal disease.

Authors:  A G Jardine; K McLaughlin
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease.

Authors:  Dana V Rizk; Orlando Gutierrez; Emily B Levitan; William M McClellan; Monika Safford; Elsayed Z Soliman; David G Warnock; Paul Muntner
Journal:  Nephrol Dial Transplant       Date:  2011-12-13       Impact factor: 5.992

3.  Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention.

Authors:  Elias B Hanna; Anita Y Chen; Matthew T Roe; Stephen D Wiviott; Caroline S Fox; Jorge F Saucedo
Journal:  JACC Cardiovasc Interv       Date:  2011-09       Impact factor: 11.195

4.  Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients.

Authors:  Tetsuo Shoji; Ikuto Masakane; Yuzo Watanabe; Kunitoshi Iseki; Yoshiharu Tsubakihara
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

5.  Clinical challenges: the intersection of diabetes, chronic kidney disease, and cardiovascular disease.

Authors:  Caitlin M Nass; Kim Reck
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

Review 6.  Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension.

Authors:  Markus P Schlaich; Henry Krum; Paul A Sobotka
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

7.  Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease.

Authors:  Alan S Go; Nisha Bansal; Malini Chandra; Phenius V Lathon; Stephen P Fortmann; Carlos Iribarren; Chi-Yuan Hsu; Mark A Hlatky
Journal:  J Am Coll Cardiol       Date:  2011-10-04       Impact factor: 24.094

8.  DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.

Authors:  Sinan Trabulus; Gulgun S Guven; Mehmet R Altiparmak; Bahadir Batar; Ozlem Tun; Ayse S Yalin; Aydin Tunckale; Mehmet Guven
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

9.  Connecting the C's: coronaries, creatinine, compliance, CRUSADE.

Authors:  Alan K Berger; Charles A Herzog
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

10.  The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction.

Authors:  Hans-Peter Hobbach; C Michael Gibson; Robert P Giugliano; Julia Hundertmark; Christel Schaeffer; Wassillij Tscherleniak; Peter Schuster
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.